S U Berlangieri

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. ncbi request reprint F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer
    S U Berlangieri
    Department of Nuclear Medicine and Centre for Positron Emission Tomography, Austin and Repatriation Medical Centre, Heidelberg, Australia
    Eur J Cardiothorac Surg 16:S25-30. 1999
  2. doi request reprint Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma
    S T Lee
    Centre for PET, Austin Health, Heidelberg, Victoria, Australia
    Mol Imaging Biol 11:473-9. 2009
  3. ncbi request reprint Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma
    S Ramdave
    Department of Nuclear Medicine and Centre for PET, Department of Nephrology, Oncology Unit, Ludwig Institute for Cancer Research, Austin and Repatriation Medical Centre, Heidelberg, Australia
    J Urol 166:825-30. 2001
  4. ncbi request reprint Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions
    S T Lee
    Centre for PET, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia
    Mol Imaging Biol 10:48-53. 2008

Collaborators

Detail Information

Publications4

  1. ncbi request reprint F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer
    S U Berlangieri
    Department of Nuclear Medicine and Centre for Positron Emission Tomography, Austin and Repatriation Medical Centre, Heidelberg, Australia
    Eur J Cardiothorac Surg 16:S25-30. 1999
    ..The analysis group consists of 50 patients, 37 men and 13 women, mean age 64 years (range, 41-78 years)...
  2. doi request reprint Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma
    S T Lee
    Centre for PET, Austin Health, Heidelberg, Victoria, Australia
    Mol Imaging Biol 11:473-9. 2009
    ....
  3. ncbi request reprint Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma
    S Ramdave
    Department of Nuclear Medicine and Centre for PET, Department of Nephrology, Oncology Unit, Ludwig Institute for Cancer Research, Austin and Repatriation Medical Centre, Heidelberg, Australia
    J Urol 166:825-30. 2001
    ..FDG-PET may have a role in the diagnostic evaluation of patients with renal cell carcinoma preoperatively and staging of metastatic disease...
  4. ncbi request reprint Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions
    S T Lee
    Centre for PET, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia
    Mol Imaging Biol 10:48-53. 2008
    ....